Prospects and challenges for expert evidence at the UPC
However, expert evidence on economic issues is likely to become increasingly important for UPC proceedings in the near term. CRA consultants Andrew Tepperman,...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.
CRA has a reputation for delivering rigorous analysis and expert testimony. Economic expertise is complemented by experience assisting life sciences companies with business and policy issues. This combination allows CRA to provide effective expert testimony and support.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comHowever, expert evidence on economic issues is likely to become increasingly important for UPC proceedings in the near term. CRA consultants Andrew Tepperman,...
In this article titled “Smallest saleable patent-practicing unit in life sciences disputes,” author Erin McDermott examines methods for calculating damages in...
Erin McDermott moderates the session exploring practical strategies for balancing caregiving responsibilities with professional goals. Caring for a parent,...
Erin McDermott moderates the session on the issue of balancing work and raising children and will explore practical strategies for thriving as a parent while...